Intensification of insulin therapy used in type-2 diabetes patients treated by the association of oral diabetes medication and basal insulin FRESH-PEF88-en Franck VIGNAL Intensification of insulin therapy used in type-2 diabetes patients treated by the association of oral diabetes medication and basal insulin INTENSIVE FRESH-PEF88-en 88 FRESH-PEF88 Franck VIGNAL SANOFI (FRANCE) Epidemiology France Portal (PEF) AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) null Franck;VIGNAL intensification of insulin therapy Endocrinology Type 2 diabetes mellitus Describe the evolution of HbA1c at 6 months under different therapeutic strategies for the intensification of insulin therapy used in type-2 diabetes patients treated by the association of oral diabetes medication and basal insulin requiring the adding of rapid insulin null France Individuals Patients population Male Female Middle Aged (45 to 64 years) Aged (65 to 79 years) man or woman, over the age of 18 years, having type-2 diabetes meeting the criteria of the HAS: treated by the association of oral diabetes medication and basal insulin (semi slow or slow-acting) and requiring the adding of rapid insulin. Clinical data Biological data Health event/morbidity One-time cross-sectional study Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Other Observational Study Observational Study 389 Completed study To be defined Access on specific project only